June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Ethnicity/race and end-stage renal disease, but not glycemic control, are significantly associated with proliferative diabetic retinopathy
Author Affiliations & Notes
  • Rushi N Mankad
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
  • Lauren Alexa Marek
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
  • Gabriella Acosta
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
  • Andrea Cabrera
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
  • Finny Monickaraj
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
    Surgery, New Mexico VA Health Care System, Albuquerque, New Mexico, United States
  • Arup Das
    Ophthalmology, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States
    Surgery, New Mexico VA Health Care System, Albuquerque, New Mexico, United States
  • Footnotes
    Commercial Relationships   Rushi Mankad, None; Lauren Marek, None; Gabriella Acosta, None; Andrea Cabrera, None; Finny Monickaraj, None; Arup Das, None
  • Footnotes
    Support  NIH R01 EY028606-01A1
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1118. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rushi N Mankad, Lauren Alexa Marek, Gabriella Acosta, Andrea Cabrera, Finny Monickaraj, Arup Das; Ethnicity/race and end-stage renal disease, but not glycemic control, are significantly associated with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1118.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The development of sight-threatening complications of diabetes, namely proliferative diabetic retinopathy (PDR), is understood to be a consequence of several modifiable and non-modifiable factors. We performed a cross-sectional, observational study to identify these factors that are significantly associated with the development of PDR.

Methods : Data was collected from two patient cohorts with type 1 or type 2 diabetes seen between February 1, 2018 and February 1, 2020: a group of 293 patients with confirmed PDR and a control group of 69 patients with confirmed mild nonproliferative diabetic retinopathy (NPDR). Patients in the PDR group were identified by ICD-10 codes and confirmed with a history of panretinal photocoagulation and/or pars plana vitrectomy for vitreous hemorrhage. Data was obtained by an extensive chart review of several systemic parameters. Statistical analysis was done via two-sample t-test for continuous variables and Chi-squared test or Fisher exact test for categorical variables.

Results : Our analysis revealed that the development of PDR was significantly associated with exogenous insulin use (p<0.001), elevated systolic BP (p=0.004), presence of macroalbuminuria (p<0.001), history of dialysis (p=0.002), and decreased GFR (p=0.024). In our cohort, the prevalence of PDR was higher in both Hispanics and American Indians than for Whites/Anglos. There was a lack of association between HbA1c levels and PDR (p=0.784). The majority of PDR patients (56.8%) had good glycemic control (HbA1c<7.5%); similarly, the majority of mild NPDR patients (58%) had poor glycemic control (HbA1c≥7.5%). No association was found with total cholesterol (p=0.713), LDL (p=0.355), HDL (p=0.440), and triglyceride (p=0.412) levels.

Conclusions : The data suggests that glycemic control is unrelated to the development of PDR, as the majority of our PDR cohort had good glycemic control. The highest incidence of PDR was seen among American Indians and Hispanics. There is a strong association between end-stage renal disease (ESRD) and PDR. Our findings indicate that “other factors,” such as genomics, may play a stronger role in development of PDR.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×